{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-013999","form_type":"8-K","ticker":"SWKHL","cik":"0001089907","company_name":"SWK Holdings Corp","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.903831+00:00","generated_at":"2026-05-24T09:42:35.357752+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SWK Holdings monetizes royalty portfolio for $51.3M; plans dividend","bullets":["ANI Pharmaceuticals exercised buyout of Iluvien royalty for ~$17.3M.","Definitive agreement with Soleus Capital to sell remaining performing royalties for ~$34.0M.","Total $51.3M represents ~$1.0M gain over book value of $50.3M as of Dec 31, 2024.","Soleus transaction expected to close in ~2 weeks; dividend to be declared at closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-013999","json":"https://secwatch.observer/filing/0001628280-25-013999.json","markdown":"https://secwatch.observer/filing/0001628280-25-013999.md","text":"https://secwatch.observer/filing/0001628280-25-013999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1089907/000162828025013999/0001628280-25-013999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1089907/000162828025013999/swkh-20250320.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T09:42:35.357752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}